NCT05787652

Brief Summary

Adults Regulating Their weight Everyday with Mobile Internet Support (ARTEMIS) is a randomised controlled trial evaluating the effectiveness of a mobile app based weight loss intervention designed to increase self-regulation in adults living with obesity.

Trial Health

55
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
1,294

participants targeted

Target at P75+ for not_applicable obesity

Timeline
Completed

Started Mar 2023

Geographic Reach
1 country

1 active site

Status
active not recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

February 28, 2023

Completed
24 days until next milestone

Study Start

First participant enrolled

March 24, 2023

Completed
4 days until next milestone

First Posted

Study publicly available on registry

March 28, 2023

Completed
2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 23, 2025

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

March 23, 2025

Completed
Last Updated

November 20, 2024

Status Verified

November 1, 2024

Enrollment Period

2 years

First QC Date

February 28, 2023

Last Update Submit

November 15, 2024

Conditions

Keywords

ObesityDigital interventionMobile appSelf-regulationWeight loss

Outcome Measures

Primary Outcomes (2)

  • Change in body weight

    To assess if the intervention achieves significantly greater weight loss than the no-treatment control group.

    6 months (baseline to 26-week follow up)

  • Proportion of participants achieving ≥ 5% loss in body weight

    To assess if the intervention achieves significantly greater weight loss than the no-treatment control group.

    6 months (baseline to 26-week follow up)

Secondary Outcomes (3)

  • Change in body weight

    12 weeks (baseline to 12-week follow up)

  • Proportion of participants achieving ≥ 5% loss in body weight

    12 weeks (baseline to 12-week follow up)

  • Change in the proportion of participants scoring above threshold (> 7) on a modified Eating Disorders Examination - Questionnaire Short Form (EDE-QS)

    12- and 26-week follow up (baseline to 12 and 26-week follow up)

Other Outcomes (8)

  • Number of days with any app engagement

    26 weeks

  • Number of daily weight readings

    26 weeks

  • Number of daily actions selected

    26 weeks

  • +5 more other outcomes

Study Arms (2)

ARTEMIS mobile app

EXPERIMENTAL

Intervention participants will be asked to download the ARTEMIS app in the Apple or Google Play app stores. The app will comprise of daily self-weighing, daily weight-recording, daily action-planning, and weekly reports and reflection. Daily weight loss action plans will predominantly relate to diet, physical activity and sleep, and comprise of eight categories, to be chosen by participants and rotated on a weekly basis, each with 5-10 actions, to be chosen by participants and rotated on a daily basis. Participants can explore and engage in all of these actions for as long as they wish within the 26-weeks of the intervention but will be recommended to continue within the 'active exploratory phase' of the intervention for at least four weeks, before moving to a 'maintenance phase', where participants continue with the actions which worked best for them in the 'active exploratory phase'.

Behavioral: ARTEMIS mobile app

Control

NO INTERVENTION

Control group participants will receive no intervention. They will be thanked for taking part in the study, advised that they may want to lose weight on their own and reminded of the next assessment at 12 weeks. The investigators will explain the value of control groups in randomised trials and the impact that remaining in follow-up has for the impact of the trial. They will also be reminded that they will receive equal financial reimbursement.

Interventions

Access to a self-regulation based mobile application.

ARTEMIS mobile app

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)
Participation is open to those who meet the following eligibility criteria: * aged ≥ 18 years; * living with obesity (BMI ≥ 30 if of white ethnicity; ≥ 27.5 for all other ethnic groups); * full- time residents in the UK, without the intention to move outside the UK within the next 12 months; * able to access the internet with a smartphone; * able to access and use a digital weighing scale; * can understand English; * not presently signed up with an intention to attend, or have in the previous three months attended, a weight management programme; * not currently participating in another weight management study; * not lost \> 5 kg (10 pounds) body weight in the previous six months; * not undergone bariatric surgery, or presently scheduled to have bariatric surgery; * not pregnant, or planning a pregnancy in the next 12 months; * not previously been diagnosed with an eating disorder; * not recently been diagnosed with a disease, or expected to undergo treatment for a disease, associated with substantial weight loss e.g., cancer treatment.

Contact the study team to discuss eligibility requirements. They can help determine if this study is right for you.

Sponsors & Collaborators

Study Sites (1)

Online social media platforms (Meta (Facebook, Instagram, Google, Twitter)

London, United Kingdom

Location

Related Publications (1)

  • Doody P, Wren GM, Mounsey S, Haasova S, Stewart C, Haffner SJP, Jebb SA, Aveyard P. The effectiveness and safety of a mobile application-based self-regulation intervention to support weight loss among adults living with obesity: a large-scale pragmatic randomised controlled trial. BMC Med. 2025 Nov 29;24(1):6. doi: 10.1186/s12916-025-04519-8.

MeSH Terms

Conditions

ObesitySelf-ControlWeight Loss

Condition Hierarchy (Ancestors)

OverweightOvernutritionNutrition DisordersNutritional and Metabolic DiseasesBody WeightSigns and SymptomsPathological Conditions, Signs and SymptomsSocial BehaviorBehaviorBody Weight Changes

Study Officials

  • Paul Aveyard, PhD

    University of Oxford

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Masking Details
It will not be possible to blind participants or trial staff to treatment allocation, as the control group receives no intervention and participants will be aware of the general nature of the study. However, all follow-up is done remotely and will therefore be unbiased.
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: This is a parallel group, randomised, controlled superiority trial.
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

February 28, 2023

First Posted

March 28, 2023

Study Start

March 24, 2023

Primary Completion

March 23, 2025

Study Completion

March 23, 2025

Last Updated

November 20, 2024

Record last verified: 2024-11

Data Sharing

IPD Sharing
Will not share

Locations